Predictive performance and clinical utility of HCC risk scores in chronic hepatitis C: a comparative study-Reference-Cited by-同舟云学术

Predictive performance and clinical utility of HCC risk scores in chronic hepatitis C: a comparative study

Published:2022-01-16 Issue:1 Volume:16 Page:159-170
ISSN:1936-0533
Container-title:Hepatology International
language:en
Short-container-title:Hepatol Int

Author:

Shiha Gamal^ORCID,Mikhail Nabiel N. H.,Soliman Reham,Hassan Ayman,Eslam Mohammed

Publisher

Springer Science and Business Media LLC

Subject

Hepatology

Link

https://link.springer.com/content/pdf/10.1007/s12072-021-10284-6.pdf

Reference50 articles.

1. WHO. Global Hepatitis Report, 2017. Geneva: World Health Organization; 2017. http://www.who.int/hepatitis/publications/global-hepatitis-report2017/en/. Accessed 20 Mar 2021.

2. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of hepatocellular carcinoma. J Hepatol 2018;69(1):182–236.

3. Li DK, Ren Y, Fierer DS, Rutledge S, Shaikh OS, Lo Re V III, et al. The short-term incidence of hepatocellular carcinoma is not increased after hepatitis C treatment with direct-acting antivirals: an ERCHIVES study. Hepatology 2018;67(6):2244–2253.

4. Carrat F, Fontaine H, Dorival C, Simony M, Diallo A, Hezode C, et al. Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study. Lancet 2019;393(10179):1453–1464.

5. Ide T, Koga H, Nakano M, Hashimoto S, Yatsuhashi H, Higuchi N, et al. Direct-acting antiviral agents do not increase the incidence of hepatocellular carcinoma development: a prospective, multicenter study. Hepatol Int 2019;13:293–301.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk factors for hepatocellular carcinoma associated with hepatitis C genotype 3 infection: A systematic review;World Journal of Gastrointestinal Oncology;2024-04-15

2. Risk stratification and early detection biomarkers for precision HCC screening;Hepatology;2022-10-11

3. Construction and application of liver cancer models in vitro;Engineered Regeneration;2022-09

4. International multicenter validation of GES score for HCC risk stratification in chronic hepatitis C patients;Journal of Viral Hepatitis;2022-06-24

5. Reply to: The best predictive model for post-SVR HCC: can it be universal?;Hepatology International;2022-05-12